Author:
Wang Minghua,Zhang Guoning,Wang Yujia,Wang Juxian,Zhu Mei,Cen Shan,Wang Yucheng
Funder
National Natural Science Foundation of China
Key New Drug Creation and Manufacturing Program
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inhibitory efficiency of quinazoline derivatives against SARS-CoV-2: virtual screening and molecular dynamics study;Proceedings of the Indian National Science Academy;2024-08-01
2. A series of quinazolin‐4(3H)‐one‐morpholine hybrids as anti‐lung‐cancer agents: Synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies;Chemical Biology & Drug Design;2024-07
3. Glutamic acid-catalyzed synthesis of dihydroquinazolinone: anticancer activity, electrochemical behavior, molecular docking, dynamics, simulations and drug-likeness studies;Research on Chemical Intermediates;2024-05-27
4. A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives;Archiv der Pharmazie;2024-05-22
5. BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir;Antimicrobial Agents and Chemotherapy;2024-04-03